| scholarly article | Q13442814 |
| P2093 | author name string | Whiting PJ | |
| Ragan CI | |||
| Hadingham KL | |||
| Palmer KJ | |||
| Le Bourdelles B | |||
| Wingrove P | |||
| P433 | issue | 6 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Gamma-aminobutyric acid type A receptor subunit alpha2 | Q21114582 |
| P304 | page(s) | 970-975 | |
| P577 | publication date | 1993-06-01 | |
| P1433 | published in | Molecular Pharmacology | Q1943386 |
| P1476 | title | Cloning of cDNA sequences encoding human alpha 2 and alpha 3 gamma-aminobutyric acidA receptor subunits and characterization of the benzodiazepine pharmacology of recombinant alpha 1-, alpha 2-, alpha 3-, and alpha 5-containing human gamma-aminobutyric acidA receptors | |
| P478 | volume | 43 |
| Q33635910 | A therapeutic dose of zolpidem reduces thalamic GABA in healthy volunteers: a proton MRS study at 4 T. |
| Q24644809 | Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond |
| Q24677350 | Activation of single heteromeric GABA(A) receptor ion channels by full and partial agonists |
| Q28537823 | Alterations in brain-derived neurotrophic factor in the mouse hippocampus following acute but not repeated benzodiazepine treatment |
| Q34061180 | Altering the relative abundance of GABA A receptor subunits changes GABA- and ethanol-responses in Xenopus oocytes |
| Q51607669 | An autoradiographic study comparing the interactions of 3 alpha-OH-5 alpha-pregnan-20-one, pregnenolone sulfate and pentobarbital with [3S]-TBPS binding sites and their modulation by GABA in different structures of the rat brain. |
| Q43261573 | Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors |
| Q34574831 | Applications of linking PBPK and PD models to predict the impact of genotypic variability, formulation differences, differences in target binding capacity and target site drug concentrations on drug responses and variability |
| Q35873298 | Barbiturate interactions at the human GABAA receptor: dependence on receptor subunit combination |
| Q37461891 | Brain lipids that induce sleep are novel modulators of 5-hydroxytrypamine receptors |
| Q42144042 | Characterisation of the contribution of the GABA-benzodiazepine α1 receptor subtype to [(11)C]Ro15-4513 PET images |
| Q24672278 | Characterization of the electrophysiological and pharmacological effects of 4-iodo-2,6-diisopropylphenol, a propofol analogue devoid of sedative-anaesthetic properties |
| Q37688234 | Cognition-impairing effects of benzodiazepine-type drugs: role of GABAA receptor subtypes in an executive function task in rhesus monkeys |
| Q34275459 | Design, synthesis, and subtype selectivity of 3,6-disubstituted β-carbolines at Bz/GABA(A)ergic receptors. SAR and studies directed toward agents for treatment of alcohol abuse. |
| Q41063235 | Diazepam enhancement of GABA-gated currents in binary and ternary GABAA receptors: relationship to benzodiazepine binding site density |
| Q33756800 | Differential modulatory actions of the volatile convulsant flurothyl and its anesthetic isomer at inhibitory ligand-gated ion channels |
| Q33618656 | Discriminative stimulus effects of L-838,417 (7-tert-butyl-3-(2,5-difluoro-phenyl)-6-(2-methyl-2H-[1,2,4]triazol-3-ylmethoxy)-[1,2,4]triazolo[4,3-b]pyridazine): role of GABA(A) receptor subtypes |
| Q28366579 | Effects of GABA(A) receptor partial agonists in primary cultures of cerebellar granule neurons and cerebral cortical neurons reflect different receptor subunit compositions |
| Q28246862 | Enhanced sucrose pellet consumption induced by benzodiazepine-type drugs in squirrel monkeys: role of GABAA receptor subtypes |
| Q46807874 | Evidence for a significant role of alpha 3-containing GABAA receptors in mediating the anxiolytic effects of benzodiazepines. |
| Q41333145 | Expression of functional GABAA receptors in neuroendocrine gastropancreatic cells |
| Q48403423 | Extrasynaptic alphabeta subunit GABAA receptors on rat hippocampal pyramidal neurons. |
| Q30479407 | GABA(A) receptors and their associated proteins: implications in the etiology and treatment of schizophrenia and related disorders |
| Q37104140 | GABA(A) receptors in normal development and seizures: friends or foes? |
| Q36820566 | GABA(A) receptors: structure and function in the basal ganglia |
| Q50297115 | GABR heteropentamers:GABA transport Cl- from extracellular region to cytosol |
| Q24595524 | General anaesthetic actions on ligand-gated ion channels |
| Q35765941 | Human locus coeruleus neurons express the GABA(A) receptor gamma2 subunit gene and produce benzodiazepine binding |
| Q48712752 | Involvement of diazepam-insensitive benzodiazepine receptors in the suppression of DOI-induced head-twitch responses in diabetic mice |
| Q28366642 | Methionine 286 in transmembrane domain 3 of the GABAA receptor beta subunit controls a binding cavity for propofol and other alkylphenol general anesthetics |
| Q42036197 | Multiple modes for conferring surface expression of homomeric beta1 GABAA receptors |
| Q34429004 | Neuronally restricted RNA splicing regulates the expression of a novel GABAA receptor subunit conferring atypical functional properties [corrected; erratum to be published] |
| Q34768548 | Novel discriminative stimulus effects of TPA023B, subtype-selective gamma-aminobutyric-acid(A)/benzodiazepine modulator: comparisons with zolpidem, lorazepam, and TPA023 |
| Q33810376 | Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats? |
| Q39551842 | Quantification of [11C]Ro15-4513 GABAAα5 specific binding and regional selectivity in humans. |
| Q34860798 | RO4938581, a novel cognitive enhancer acting at GABAA alpha5 subunit-containing receptors |
| Q36947582 | Risk of falling and hypnotic drugs: retrospective study of inpatients |
| Q34518723 | Ro 15-4513 Antagonizes Alcohol-Induced Sedation in Mice Through αβγ2-type GABA(A) Receptors. |
| Q34360939 | SB-205384 is a positive allosteric modulator of recombinant GABAA receptors containing rat α3, α5, or α6 subunit subtypes coexpressed with β3 and γ2 subunits |
| Q35047079 | Salicylidene salicylhydrazide, a selective inhibitor of beta 1-containing GABAA receptors |
| Q24676214 | Selective labelling of diazepam-insensitive GABAA receptors in vivo using [3H]Ro 15-4513 |
| Q48104692 | The Search for a Subtype-Selective PET Imaging Agent for the GABAA Receptor Complex: Evaluation of the Radiotracer [11C]ADO in Nonhuman Primates |
| Q28343937 | The actions of ether, alcohol and alkane general anaesthetics on GABAA and glycine receptors and the effects of TM2 and TM3 mutations |
| Q34481002 | The diversity of GABAA receptors. Pharmacological and electrophysiological properties of GABAA channel subtypes |
| Q24654417 | The interaction of the general anesthetic etomidate with the gamma-aminobutyric acid type A receptor is influenced by a single amino acid |
| Q34341226 | The modulatory action of loreclezole at the gamma-aminobutyric acid type A receptor is determined by a single amino acid in the beta 2 and beta 3 subunit |
| Q36948429 | The non-benzodiazepine hypnotic zolpidem impairs sleep-dependent cortical plasticity. |
| Q35045966 | Thymol, a constituent of thyme essential oil, is a positive allosteric modulator of human GABA(A) receptors and a homo-oligomeric GABA receptor from Drosophila melanogaster |
| Q36838950 | Zolpidem generalization and antagonism in male and female cynomolgus monkeys trained to discriminate 1.0 or 2.0 g/kg ethanol |
Search more.